The patient perspective on remission in rheumatoid arthritis: "You've got limits, but you're back to being you again'

被引:71
作者
van Tuyl, Lilian H. D. [1 ]
Hewlett, Sarah [2 ]
Sadlonova, Martina [3 ]
Davis, Bev [4 ]
Flurey, Caroline [2 ]
Hoogland, Wijnanda [1 ]
Kirwan, John [5 ]
Sanderson, Tessa [2 ]
van Schaardenburg, Dirkjan [6 ]
Scholte-Voshaar, Marieke [1 ]
Smolen, Josef [3 ]
Stamm, Tanja [3 ]
Boers, Maarten [7 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Rheumatol, NL-1007 MB Amsterdam, Netherlands
[2] Univ W England, Nursing & Midwifery, Bristol BS16 1QY, Avon, England
[3] Med Univ Vienna, Dept Med, Div Rheumatol, Vienna, Austria
[4] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England
[5] Univ Bristol, Acad Rheumatol Unit, Bristol, Avon, England
[6] Jan van Breemen Res Inst Reade, Amsterdam, Netherlands
[7] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands
关键词
Rheumatoid Arthritis; Qualitative Research; Outcomes Research; Patient Perspective; DISEASE-ACTIVITY; CLINICAL-TRIALS; AMERICAN-COLLEGE; OUTCOME MEASURE; LIFE IMPACT; FATIGUE; MORTALITY; RECOMMENDATIONS; INDEX;
D O I
10.1136/annrheumdis-2013-204798
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The aim of rheumatoid arthritis (RA) treatment is remission. As treatment should be targeted at outcomes relevant to patients, it is important to understand how patients perceive remission, and to assess whether the current definition of remission adequately reflects these perceptions. The objective of this study is to explore the patient perspective on remission in RA. Methods Nine focus-group discussions in Austria, The Netherlands and UK were conducted, including patients in American College of Rheumatology (ACR)/ European League of Rheumatology (EULAR) remission, self-declared remission and in moderate/high disease activity. Moderators employed a prespecified interview guide helped to engage patients in a discussion on their experience with remission. Inductive thematic analysis was performed within each country, and identified themes were discussed across countries. Results 47 RA patients (66% women, disease duration 9years) participated. Three major themes of patient-perceived remission emerged: (1) symptoms would either be absent or strongly reduced, (2) impact of the disease on daily life would diminish by increased independence, ability to do valued activities, improved mood and ability to cope; (3) leading to a return to normality, including work, family role and perception of others. Patients felt the concept of remission was influenced by ageing, side effects of medication, comorbidities, accrued damage to joints and disease duration. Opinions on duration of state, the role of medication and measurement instruments varied widely. Conclusions Patients characterise remission by the absence or reduction of symptoms, but more directly by decreased daily impact of their condition and the feeling of a return to normality. The next step is to study whether an additional patient-perceived measure of remission may add value to the ACR/EULAR definition of remission.
引用
收藏
页码:1004 / 1010
页数:7
相关论文
共 28 条
[1]   Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations [J].
Aletaha, D. ;
Landewe, R. ;
Karonitsch, T. ;
Bathon, J. ;
Boers, M. ;
Bombardier, C. ;
Bombardieri, S. ;
Choi, H. ;
Combe, B. ;
Dougados, M. ;
Emery, P. ;
Gomez-Reino, J. ;
Keystone, E. ;
Koch, G. ;
Kvien, T. K. ;
Martin-Mola, E. ;
Matucci-Cerinic, M. ;
Michaud, K. ;
O'Dell, J. ;
Paulus, H. ;
Pincus, T. ;
Richards, P. ;
Simon, L. ;
Siegel, J. ;
Smolen, J. S. ;
Sokka, T. ;
Strand, V. ;
Tugwell, P. ;
van der Heijde, D. ;
van Riel, P. ;
Vlad, S. ;
van Vollenhoven, R. ;
Ward, M. ;
Weinblatt, M. ;
Wells, G. ;
White, B. ;
Wolfe, F. ;
Zhang, B. ;
Zink, A. ;
Felson, D. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (10) :1360-1364
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]  
BOERS M, 1994, J RHEUMATOL, V21, P86
[4]   One size fits all? What counts as quality practice in (reflexive) thematic analysis? [J].
Braun, Virginia ;
Clarke, Victoria .
QUALITATIVE RESEARCH IN PSYCHOLOGY, 2021, 18 (03) :328-352
[5]  
Felson DT, 2011, ANN RHEUM DIS, V70, P404, DOI [10.1136/ard.2011.149765, 10.1002/art.30129]
[6]   THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY CORE SET OF DISEASE-ACTIVITY MEASURES FOR RHEUMATOID-ARTHRITIS CLINICAL-TRIALS [J].
FELSON, DT ;
ANDERSON, JJ ;
BOERS, M ;
BOMBARDIER, C ;
CHERNOFF, M ;
FRIED, B ;
FURST, D ;
GOLDSMITH, C ;
KIESZAK, S ;
LIGHTFOOT, R ;
PAULUS, H ;
TUGWELL, P ;
WEINBLATT, M ;
WIDMARK, R ;
WILLIAMS, HJ ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1993, 36 (06) :729-740
[7]   A TOXICITY INDEX FOR COMPARISON OF SIDE-EFFECTS AMONG DIFFERENT DRUGS [J].
FRIES, JF ;
SPITZ, PW ;
WILLIAMS, CA ;
BLOCH, DA ;
SINGH, G ;
HUBERT, HB .
ARTHRITIS AND RHEUMATISM, 1990, 33 (01) :121-130
[8]   Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative [J].
Gossec, L. ;
Dougados, M. ;
Rincheval, N. ;
Balanescu, A. ;
Boumpas, D. T. ;
Canadelo, S. ;
Carmona, L. ;
Daures, J-P ;
de Wit, M. ;
Dijkmans, B. A. C. ;
Englbrecht, M. ;
Gunendi, Z. ;
Heiberg, T. ;
Kirwan, J. R. ;
Mola, E. M. ;
Matucci-Cerinic, M. ;
Otsa, K. ;
Schett, G. ;
Sokka, T. ;
Wells, G. A. ;
Aanerud, G. J. ;
Celano, A. ;
Dudkin, A. ;
Hernandez, C. ;
Koutsogianni, K. ;
Akca, F. N. ;
Petre, A-M ;
Richards, P. ;
Scholte-Voshaar, M. ;
Von Krause, G. ;
Kvien, T. K. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (11) :1680-1685
[9]   Outcomes generated by patients with rheumatoid arthritis: How important are they? [J].
Hewlett, Sarah ;
Carr, Maggie ;
Ryan, Sarah ;
Kirwan, John ;
Richards, Pam ;
Carr, Alison ;
Hughes, Rod .
MUSCULOSKELETAL CARE, 2005, 3 (03) :131-142
[10]  
Kirwan JR, 2007, J RHEUMATOL, V34, P1174